Metribolone

From WikiMD's WELLNESSPEDIA

Metribolone (also known as methyltrienolone or R1881) is a potent, non-aromatizable androgen that is used in scientific research and has been sold online as a designer steroid. Metribolone is an oral steroid and is one of the strongest available on the market, it is also one of the most hepatotoxic and is not recommended for practical use.

History[edit]

Metribolone was first described in 1965. It was immediately recognized as an extraordinarily potent anabolic agent, significantly more potent than the reference anabolic steroid in that study, fluoxymesterone. However, its potential for liver toxicity was also quickly realized.

Pharmacology[edit]

As an AAS, metribolone is an agonist of the androgen receptor (AR), similarly to androgens like testosterone and dihydrotestosterone (DHT). It is one of the most potent AAS to have ever been synthesized, with 120–300 times the oral anabolic potency and 60–70 times the androgenic potency of methyltestosterone, and 12 times the oral anabolic potency and 2.5 times the androgenic potency of oxymetholone.

Side Effects[edit]

Metribolone is considered one of the most toxic steroids. It is both highly hepatotoxic and capable of causing damage to the liver. It also has potential side effects in many other areas, including cardiovascular complications, and potential direct neurological and mental changes. It is so dangerous that it is often used in research studies to induce damage to the liver as it is so reliably toxic.

Legal Status[edit]

In the United States, metribolone is classified as a Schedule III controlled substance under federal regulation, under the Controlled Substances Act. It is also banned by many sporting organizations, including the International Olympic Committee.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.